Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
D.A. Davidson’s Tim Ramey enjoyed shoving his vindication, re: Herbalife, in Bill Ackman’s face—see his post-reaudit victory, pre-trip to Disneyland speech here—to end last year so much that he’s planning on another year of it.
D.A. Davidson analyst Timothy Ramey, a longtime Herbalife bull, calls the stock his “single best idea” for 2014, the second year in a row he is giving it that distinction….
“Unleashed from the bear raid, Herbalife should trade on growth prospects,” Mr. Ramey wrote to clients….
“If “multilevel” were to be fully vindicated as an operating strategy, why wouldn’t Herbalife deserve to sell at 25x EPS?” Mr. Ramey asks. “It has impressive margins, huge cash flow, which it has used to benefit shareholders with aggressive share repurchase and dividend increases, and its revenue growth beats anything else we cover.”
Herbalife Is ‘Single Best Idea’ in 2014: Analyst [WSJ MoneyBeat blog]
Herbalife Analyst: I’d Like to Thank ‘Mom, Jesus and Short Sellers’ [WSJ MoneyBeat blog]